Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 4/2011

01-12-2011

Update in Thyroid Fine Needle Aspiration

Authors: William C. Faquin, Massimo Bongiovanni, Peter M. Sadow

Published in: Endocrine Pathology | Issue 4/2011

Login to get access

Abstract

Thyroid fine needle aspiration (FNA) is a safe, cost effective, and relatively accurate method for guiding the initial management of a thyroid nodule. The popularity of thyroid FNA is reflected in the fact that over 350,000 thyroid FNAs are performed each year in the USA. As we move into the next decade, several issues pertaining to thyroid FNA are being addressed including: how to better apply thyroid FNA as a differential test for follicular-patterned thyroid tumors, how to manage the atypical thyroid FNA, and how to use thyroid FNA in the evaluation of poorly differentiated thyroid carcinomas.
Literature
1.
Werga P, Wallin G, Skoog L, Hamberger B. Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management. World J Surg 2000; 24: 907–12.PubMedCrossRef
2.
Lundgren CI, Zedenius J, Skoog L. Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review. World J Surg 2008; 32: 1247–52.PubMedCrossRef
3.
Bukhari MH, Niazi S, Hanif G, et al. An updated audit of fine needle aspiration cytology procedure of solitary thyroid nodule. Diagn Cytopathol 2008; 36: 104–12.PubMedCrossRef
4.
Deveci MS, Deveci G, LiVolsi VA, Baloch ZW. Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-up. Cytojournal 2006;3:1–9.CrossRef
5.
6.
Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118: 282–9.PubMed
7.
Ravetto C, Colombo L, Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 2000; 90: 357–63.PubMedCrossRef
8.
Layfield LJ, Elsheikh TM, Fili A, Nayar R, Shidham V. Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting: the Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn Cytopathol 2004; 30: 24–30.PubMedCrossRef
9.
Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagn Cytopathol 1996; 15: 84–9.
10.
Clark D, Faquin W. Thyroid Cytopathology. Essentials in Cytopathology Series. New York: Springer 2005.
11.
Oertel YC. Fine-needle aspiration of the thyroid: technique and terminology. Endocrinol Metab Clin North Am 2007; 36: 737–51, vi-vii.
12.
Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR. Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 1989; 106: 980–5; discussion 85–6.
13.
Renshaw AA. An estimate of risk of malignancy for a benign diagnosis in thyroid fine-needle aspirates. Cancer Cytopathol 2010;118:190–195.PubMedCrossRef
14.
Kato MA, Fahey TJ. Molecular markers in thyroid cancer diagnostics. Surg Clin N Am 2009;89:1139–1155.PubMedCrossRef
15.
Nikiforov YE, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009;94:2092–2098.PubMedCrossRef
16.
Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 2008;21:S37-S43.PubMedCrossRef
17.
Ohori NP et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance.” Cancer Cytopathol 2010;118:17–23.PubMedCrossRef
18.
Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. New York, Springer, 2009.
19.
Baloch ZW, LiVolsi VA. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol 2008;36:425–437.PubMedCrossRef
20.
Baloch ZW, Fleisher S, et al. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26:41–44.PubMedCrossRef
21.
Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according toNational Cancer Institute Recommendations. Diagn Cytopathol 2010;10:731–739.
22.
Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer Cytopathol 2007;111:306–315.
23.
Krane JF, Nayar R, Renshaw AA. Atypical cells of undetermined significance. In: Ali SZ, Cibas ES, editors. The Bethesda system for reporting thyroid cytopathology. New York: Springer, 2010:37–49.CrossRef
24.
Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009;117:195–202.CrossRef
25.
Renshaw AA. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: Distinct patterns and associated risk of malignancy. Cancer Cytopathol. 2011. doi:10.​1002/​cncy.​20154.
26.
Muddegowda PH, Lingegowda J, Natesan R, Kurpad R. Divide and rule: Cytodiagnosis of thyroid lesions using pattern analysis: A study of 233 cases. Diagn Cytopathol. 2010. doi:10.​1002/​dc.​21486.
27.
Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer Cytopathol. 2009;117:298–304.CrossRef
28.
Jing X, Roh MH, Knoepp SM, Zhao L, Michael CW. Minimizing the diagnosis of "follicular lesion of undetermined significance" and identifying predictive features for neoplasia. Diagn Cytopathol. 2011;39:737–742.
29.
Mahajan A, Kasper K, Lin X, et al. Thyroid FNA atypia of undetermined significance (AUS): variability in pathologist reporting and clinical follow-up. Mod Pathol. 2011;24(1 s):98A.
30.
Weber D, Brainard J, Chen L. Atypical epithelial cells, cannot exclude papillary carcinoma, in fine needle aspiration of the thyroid. Acta Cytol. 2008;52:320–324.PubMedCrossRef
31.
Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31:1256–64.PubMedCrossRef
32.
Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer. 1983;52:1849–55PubMedCrossRef
33.
Volante M, Landolfi S, Chiusa L, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer. 2004;100:950–7.PubMedCrossRef
34.
Wreesmann VB, Ghossein RA, Patel SG, et al. Genome-wide appraisal of thyroid cancer progression. Am J Pathol 2002;161(5):1549–56.PubMedCrossRef
35.
Luna-Ortiz K, Hurtado-Lopez LM, Dominguez-Malagon H, et al. Clinical course of insular thyroid carcinoma. Med Sci Monit. 2004;10:CR108-11.
36.
Pulcrano M, Boukheris H, Talbot M, et al. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid. 2007;17:639–46.PubMedCrossRef
37.
Bongiovanni M, Bloom L, Krane JF, et al. Cytomorphologic features of poorly differentiated thyroid carcinoma: a multi-institutional analysis of 40 cases. Cancer. Cytopathol 2009.
38.
Pietribiasi F, Sapino A, Papotti M, et al. Cytologic features of poorly differentiated 'insular' carcinoma of the thyroid, as revealed by fine-needle aspiration biopsy. Am J Clin Pathol. 1990;94:687–92.PubMed
39.
Sironi M, Collini P, Cantaboni A. Fine needle aspiration cytology of insular thyroid carcinoma. A report of four cases. Acta Cytol. 1992;36:435–9.PubMed
40.
Guiter GE, Auger M, Ali SZ, et al. Cytopathology of insular carcinoma of the thyroid. Cancer. 1999;87:196–202.PubMedCrossRef
41.
Nguyen GK, Akin MR. Cytopathology of insular carcinoma of the thyroid. Diagn Cytopathol. 2001;25:325–30.PubMedCrossRef
42.
Albores-Saavedra J, Carrick K. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 2004;15:297–305.PubMedCrossRef
43.
Raphael SJ. The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocr Pathol. 2002;13:301–11.PubMedCrossRef
44.
Basolo F, Pisaturo F, Pollina LE, et al. N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid. 2000;10:19–23.PubMedCrossRef
45.
Garcia-Rostan G, Zhao H, Camp RL, et al. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol. 2003;21:3226–35.PubMedCrossRef
Metadata
Title
Update in Thyroid Fine Needle Aspiration
Authors
William C. Faquin
Massimo Bongiovanni
Peter M. Sadow
Publication date
01-12-2011
Publisher
Springer US
Published in
Endocrine Pathology / Issue 4/2011
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-011-9182-7

Other articles of this Issue 4/2011

Endocrine Pathology 4/2011 Go to the issue

ReviewPaper

Follicular-Patterned Tumors of the Thyroid: The Battle of Benign vs. Malignant vs. So-called Uncertain

Announcement

Dr. Bernd W. Scheithauer

EditorialNotes

Thyroid Leiomyosarcoma: Primary or Metastasis? That’s the Question!

ReviewPaper

Poorly Differentiated Thyroid Carcinoma. Are We There Yet?

OriginalPaper

Expression, Localization, and Phosphorylation of Akt1 in Benign and Malignant Thyroid Lesions

BriefCommunication

Is Adrenal Ovarian Thecal Metaplasia a Misnomer? Report of Three Cases of Radial Scar-Like Spindle Cell Myofibroblastic Nodule of the Adrenal Gland
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits